Expert Interview
Discussing therapies in development for plaque psoriasis with a focus on Dermavant VTAMA (tapinarof) cream and Arcutis' ZORYVE
Ticker(s): ROIV, ARQTInstitution: Private Practice
- Board-Certified dermatologist practicing cosmetic, medical, surgical and pediatric dermatology.
- Treats 5 patients with DEB and 100 patients with atopic dermatitis each month.
- Served as a sub-investigator for 10 randomized clinical drug trials for atopic dermatitis, psoriasis, systemic lupus erythematosus and cutaneous T-cell lymphoma; investigator for Dupixent’s Phase 2 AD trials.
Are You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
